These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38142448)

  • 1. Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL.
    Gerds AT; Mesa R; Burke JM; Grunwald MR; Stein BL; Squier P; Yu J; Hamer-Maansson JE; Oh ST
    Blood; 2024 Apr; 143(16):1646-1655. PubMed ID: 38142448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated White Blood Cell Levels and Thrombotic Events in Patients With Polycythemia Vera: A Real-World Analysis of Veterans Health Administration Data.
    Parasuraman S; Yu J; Paranagama D; Shrestha S; Wang L; Baser O; Scherber R
    Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):63-69. PubMed ID: 31865003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data.
    Parasuraman S; Yu J; Paranagama D; Shrestha S; Wang L; Baser O; Scherber R
    Ann Hematol; 2019 Nov; 98(11):2533-2539. PubMed ID: 31552445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematocrit, White Blood Cells, and Thrombotic Events in the Veteran Population With Polycythemia Vera.
    Tashi T
    Fed Pract; 2022 May; 39(Suppl 2):S43-S46. PubMed ID: 35929004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice.
    Chojecki A; Boselli D; Dortilus A; Hamadeh I; Begley S; Chen T; Bose R; Podoltsev N; Zeidan AM; Balmaceda NB; Yacoub A; Ai J; Knight TG; Ragon BK; Shah NA; Sanikommu SR; Symanowski J; Mesa R; Grunwald MR
    Ann Hematol; 2024 Aug; 103(8):2837-2843. PubMed ID: 38662203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world treatments and thrombotic events in polycythemia vera patients in the USA.
    Verstovsek S; Pemmaraju N; Reaven NL; Funk SE; Woody T; Valone F; Gupta S
    Ann Hematol; 2023 Mar; 102(3):571-581. PubMed ID: 36637474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The haematocrit and platelet target in polycythemia vera.
    Di Nisio M; Barbui T; Di Gennaro L; Borrelli G; Finazzi G; Landolfi R; Leone G; Marfisi R; Porreca E; Ruggeri M; Rutjes AW; Tognoni G; Vannucchi AM; Marchioli R;
    Br J Haematol; 2007 Jan; 136(2):249-59. PubMed ID: 17156406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
    Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
    Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera in the United States.
    Grunwald MR; Stein BL; Boccia RV; Oh ST; Paranagama D; Parasuraman S; Colucci P; Mesa R
    Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):788-795.e2. PubMed ID: 30245100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhage in patients with polycythemia vera receiving aspirin with an anticoagulant: a prospective, observational study.
    Zwicker JI; Paranagama D; Lessen DS; Colucci PM; Grunwald MR
    Haematologica; 2022 May; 107(5):1106-1110. PubMed ID: 34162181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Predictive Value of Neutrophil-Lymphocyte Ratio in Patients with Polycythemia Vera at the Time of Initial Diagnosis for Thrombotic Events.
    Wang X; Tu Y; Cao M; Jiang X; Yang Y; Zhang X; Lai H; Tu H; Li J
    Biomed Res Int; 2022; 2022():9343951. PubMed ID: 35978626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.
    Landolfi R; Di Gennaro L; Barbui T; De Stefano V; Finazzi G; Marfisi R; Tognoni G; Marchioli R;
    Blood; 2007 Mar; 109(6):2446-52. PubMed ID: 17105814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL Study.
    Grunwald MR; Burke JM; Kuter DJ; Gerds AT; Stein B; Walshauser MA; Parasuraman S; Colucci P; Paranagama D; Savona MR; Mesa R
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):579-584.e1. PubMed ID: 31303457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.
    Wehmeier A; Daum I; Jamin H; Schneider W
    Ann Hematol; 1991 Aug; 63(2):101-6. PubMed ID: 1912029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic complications of polycythemia vera.
    Varma S; Sharma A; Malhotra P; Kumari S; Jain S; Varma N
    Hematology; 2008 Dec; 13(6):319-23. PubMed ID: 19055858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival and prognosis of patients with polycythemia vera: a study of 816 patients in a single Chinese center].
    Bai J; Shi H; Ai L; Zhang L; Zhou Y; Li Z; Zhao Y; Sheng M; Li D; Li H; Qian L; Mi Y; Xiao Z; Zheng Y; Yang R; Xue Y
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(18):1364-8. PubMed ID: 26178350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical Analysis of Gene Mutation and Vascular Events in Patients with BCR/ABL Negative Myeloproliferative Neoplasms].
    Hu BD; Chen L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):813-818. PubMed ID: 35680810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of thrombogenesis in polycythemia vera.
    Kroll MH; Michaelis LC; Verstovsek S
    Blood Rev; 2015 Jul; 29(4):215-21. PubMed ID: 25577686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.
    Vannucchi AM; Antonioli E; Guglielmelli P; Rambaldi A; Barosi G; Marchioli R; Marfisi RM; Finazzi G; Guerini V; Fabris F; Randi ML; De Stefano V; Caberlon S; Tafuri A; Ruggeri M; Specchia G; Liso V; Rossi E; Pogliani E; Gugliotta L; Bosi A; Barbui T
    Blood; 2007 Aug; 110(3):840-6. PubMed ID: 17379742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Overall survival and prognosis of patients with polycythemia vera: an analysis based on 906 patients from a single center].
    Liu D; Xu ZF; Zhang PH; Ma J; Qin TJ; Qu SQ; Sun XJ; Li B; Pan LJ; Jia YJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):898-903. PubMed ID: 35045650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.